Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More nonsmokers are getting lung cancer: Oncologist explains why

2.

FDA Approves CAR-T Product Use for Myeloma Early.

3.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

4.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

5.

ALK-positive lung cancer trial results show unprecedented progression-free survival.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot